Portal de Periódicos da CAPES

Immunology of Reactions in Leprosy

1988; Wiley; Volume: 27; Issue: 3 Linguagem: Inglês

10.1111/j.1365-4362.1988.tb04919.x

1365-4632

Virendra Sehgal, Govind Srivastava, Joseph A. Sundharam,

Acne and Rosacea Treatments and Effects

International Journal of DermatologyVolume 27, Issue 3 p. 157-162 Immunology of Reactions in Leprosy Current Status Virendra N. Sehgal M.D., Corresponding Author Virendra N. Sehgal M.D. From the Department of Dermatology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant Hospitals, New Delhi, IndiaAddress for correspondence: Prof. V. N. Sehgal, A-6, Panchwati, Delhi 110033, India.Search for more papers by this authorG. Srivastava M.D., G. Srivastava M.D. From the Department of Dermatology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant Hospitals, New Delhi, IndiaSearch for more papers by this authorJ. A. Sundharam M.D., J. A. Sundharam M.D. From the Department of Dermatology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant Hospitals, New Delhi, IndiaSearch for more papers by this author Virendra N. Sehgal M.D., Corresponding Author Virendra N. Sehgal M.D. From the Department of Dermatology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant Hospitals, New Delhi, IndiaAddress for correspondence: Prof. V. N. Sehgal, A-6, Panchwati, Delhi 110033, India.Search for more papers by this authorG. Srivastava M.D., G. Srivastava M.D. From the Department of Dermatology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant Hospitals, New Delhi, IndiaSearch for more papers by this authorJ. A. Sundharam M.D., J. A. Sundharam M.D. From the Department of Dermatology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant Hospitals, New Delhi, IndiaSearch for more papers by this author First published: April 1988 https://doi.org/10.1111/j.1365-4362.1988.tb04919.xCitations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Sehgal VN. Reactions in leprosy: clinical aspects. Int J Dermatol. 1987; 26: 278– 285. 2 Waters MFR, Turk JL, Wemambu SNC. Mechanism of reactions in leprosy. Int J Lepr. 1971; 39: 417– 428. 3 Rees RJW, Weddell AC. A experimental model in mice for studying the reversal reaction. Int J Lepr. 1968; 38: 629– 630. 4 Rook CAW. Three forms of delayed immune responses evoked by mycobacteria. Nature. 1978; 271: 64– 65. 5 Godal T, Myrvang B, Samuel DR, et al. Mechanism of reaction in borderline tuberculoid leprosy. Acta Pathol Microbiol Scand. 1973; 236(Suppl): 45– 53. 6 Barnetson RStc, Bjune G, Pearson JMH, et al. Antigenic hetrogeneity in patients with reactions in borderline leprosy. Br Med J. 1975; 4: 435– 437. 7 Bjune G, Barnetson RS, Ridley DS, et al. Lymphocyte transformation test in leprosy: correlation of response with inflammation of the lesion. Clin Exp Immunol. 1976; 25: 85– 94. 8 Youmans CP. Relation between delayed hypersensitivity and protective immunity in tuberculosis. Am Rev Resp Dis. 1975; 111: 109– 113. 9 Bjune G, Barnetson RS. Plasma factors in delayed type hypersensitivity: augmentation of lymphocyte responses in borderline leprosy reactions. Clin Exp Immunol. 1976; 26: 397– 402. 10 Saha K, Mittal MM, Maheshwari HB. Passive transfer of immunity into leprosy patients by transfusion of Lawrence transfer factor. J Clin Microbiol. 1975; 1: 279– 288. 11 Duncan ME, Pearson JMH. Neuritis in pregnancy and lactation. Int J Lepr. 1982; 50: 31– 88. 12 Bjune G. Reactions in leprosy. Lepr Rev. 1983; 54(special issue): 61– 67. 13 Sehgal VN, Gautam RK, Sharma VK. Immunoprofile of reactions in leprosy. Int J Dermatol. 1986; 25: 240– 244. 14 Barnetson RStc, Bjune G, Pearson JMH, et al. Cell-mediated and humoral immunity in reversal reactions. In J Lepr. (1976); 44: 267– 274. 15 Laal S, Nath I, Bhutani LK. Suppressor cells in leprosy reactions (abstract). XII International Leprosy Congress. Int J Lepr. 1984; 52(Suppl): 696. 16 Nanayan RB, Laal S, Sharma AK, et al. Differences in predominant T cell prototypes and distribution pattern in reactional tuberculoid and lepromatous leprosy. Clin Exp Immunol. 1984; 55: 623– 628. 17 Desikan KV. Morphological changes in the lymph nodes in leprosy with special reference to the unstable forms. Lepr India. 1974; 46: 35– 38. 18 Jopling WH. Leprosy reactions. In: Handbook of Leprosy, 3rd ed. London : William Heinemann Medical Books Ltd, 1985: 68– 77. 19 Converse PJ, Humbler D, Mshana R, et al. NK and K cell function in lepromatous patients: increased NK cell activity in patients undergoing reaction (abstract). XII International Leprosy Congress. Int J Lepr. 1984; 52(Suppl): 698. 20 Tung KSR, Nelson K, Rubin L, et al. Serum soluble interleukin receptors in leprosy patients (Abstract). Twentieth Joint Leprosy Research Conference. Int J Lepr. 1984; 53: 719. 21 Jolliffe DS. Leprosy reactional states and their treatment. Br J Dermatol. 1977; 97: 345– 353. 22 Ridley DS. Skin Biopsy in Leprosy. Documenta Geigy Publication. 1977: 47– 51. 23 Ridley DS. Hypersensitivity and immunity reactions and classification. Lepr Rev. 1976; 47: 171– 174. 24 Gelber RH, Epstein WV, Fasal P, et al. Erythema nodosum leprosum: an immune complex disorder. Int J Lepr. 1972; 40: 455– 456. 25 Moran CJ, Ryder G, Turk JL, et al. Evidence of circulating immune complexes in lepromatous leprosy. Lancet. 1972; 2: 572– 573. 26 Rojas-Epinosa O, Mendez Navare III, Extra DA, et al. Presence of C1q reactive immune complexes in lepromatous leprosy. Clin Exp Immunol. 1972; 12: 215– 223. 27 Valentija RM, Faber WR, Lai-A-fat RF, et al. Immune complexes in leprosy patients from an endemic and non-endemic areas. Clin Immunol Immunopathol. 1982; 22: 194– 202. 28 Bjorvath B, Barnetson FS, Kronvall GK, et al. Immune complexes and complement hypercatabolism in patients with leprosy. Clin Exp Immunol. 1976; 26: 388– 396. 29 Wemambu SNC, Turk JL, Waters MFR, et al. ENL—a clinical manifestation of the Arthus phenomenon. Lancet. 1969; 2: 933– 935. 30 Lourie SJ, Gloosky M. Complement determinations in the synovial fluid and serum of a patient with ENL. Int J Lepr. 1975; 43: 242– 245. 31 Srivastava LM, Agarwal DP, Goldee HW, et al. Biochemical, immunological and genetic studies in leprosy. II: profile of immunoglobulin, complements components and C-reactive protein in the sera of leprosy patients and healthy controls. Tropenmed Parasitol. 1975; 26: 212– 218. 32 Saha K, Chakrabarty AK. Serum complement profiles in human leprosy and its comparison with immune complex diseases. Int J Lepr. 1977; 45: 327– 337. 33 Bullock WE. Leprosy—a model of immunological perturbation in chronic infection. J Infect Dis. 1978; 137: 341– 354. 34 Saha K, Chakraborty AK, Sharma VK, et al. An appraisal of third complement component (C3) and breakdown product (C3d) in ENL. Lepr Rev. 1982; 53: 253– 260. 35 Sen Gupta U., Sinha S, Ramu G. Immunological assessment of sera of leprosy patients. Lepr India. 1979; 5l: 43– 48. 36 Kumar B, Ganguly NK, Kaur S, et al. Complement profile in leprosy. Lepr India. 1980; 52: 217– 222. 37 Harikrishan S, Balakrishnan S, Bhatia VN. Serum immunoglobulin profile and C3 level in lepromatous leprosy patients. Lepr India. 1982; 54: 454– 460. 38 Jain VK, Verma KC, Aggarwal SS. A study of serum fibrinolytic activity in ENL. Lepr India. 1983; 55: 95– 99. 39 Quismorio FP Jr, Rea R, Chandos C, et al. Lucio's phenomenon: an immune complex deposition syndrome in lepromatous leprosy. Clin Immunol Immunopathol. 1978: 9: 184– 189. 40 Sharda DP, Parvez M, Jain AK, et al. A study of serum fibrinolytic activity in leprosy. Lepr India. 1979; 51: 203– 208. 41 Jha P, Balkrishnan K, Talwar GP, et al. Status of humoral immune responses in leprosy. Int J Lepr. 1971; 39: 14– 19. 42 Sehgal VN, Srivastava G, Gautan RK, et al. ENL in histoid leprosy. Int J Lepr. 1984; 52: 543– 544. 43 Petchclai B, Chutanodha PS, Hiraneres S, et al. Complement profile in leprosy. Am J Trop-Med Hyg. 1973; 22: 761– 765. 44 Drutz DJ, Gutman RA. The kidney in leprosy—an immunologic target organ. US-Japan cooperative Medical Science Programme. VIIth Annual Leprosy Research Conference, California. Int J Lepr. 1972; 40: 217– 218. 45 Saha K, Sharma V, Chakraborty AK, et al. Breakdown product of factor B as an index of complement activation in lepromatous leprosy and its relation with bacillary load. Scand J Immunol. 1983; 17: 37– 43. 46 Chapter 6. Hypersensitivity. In: IM Roitt. Essential Immunology, 2nd ed. Oxford : Blackwell, 1974: 129– 143. 47 Cologlu AS. Immune complex glomerulonephritis in leprosy. Lepr Rev. 1979; 50: 213– 222. 48 Johny KV, Karat ABA, Rao PSS, et al. Glomerulonephritis in leprosy—a percutaneous renal biopsy study. Lepr Rev. 1975; 46: 29– 34. 49 Ridley MJ, Russel B. An immunoperoxidase study of immunologic factors in high-immune and low-resistance granuloma in leprosy. J Pathol. 1982; 137: 149– 157. 50 Ridley MJ, Ridley DS. The immunopathology of erythema nodosum leprosum. The role of extravascular complexes. Lepr Rev. 1983; 54: 95– 107. 51 Ramanathan VD, Verma OP, Ramu G, et al. Isolation and analysis of circulating immune complexes from leprosy patients (abstract). XII International Leprosy Congress. Int J Lepr. 1984; 52: 697. 52 Welsh GP, Fajardo TT, Guinto RS. Immunoglobulin and complement levels in lepromatous leprosy in special relation to ENL and resistance. Int J Lepr. 1973: 41: 552– 554. 53 Reichlin M, Pranis RA, Gelber RH, et al. Correlation of cryoglobulin immunoglobulin G levels with ENL. Clin Immunol Immunopathol. 1977; 8: 335– 344. 54 Sharma VK, Saha K, Sehgal VN. Serum immunoglobulin and autoantibodies during and after ENL. Int J Lepr. 1983; 50: 159– 163. 55 Jain PK, Kumar A, Singh PK, et al. Complement and immunologic profile in leprosy and its reaction (abstract). XIIth International Leprosy Congress. Int J Lepr. 1984; 52(Suppl): 686. 56 Sagher F, Sheskin J, Zlotnic KA, et al. Complement and immunologic determinants in leprosy and lepra reaction. Int J Lepr. 1971: 39: 541– 553. 57 Andreoli A, Brett SJ, Drapes P, et al. Changes in circulating antibody levels to the major phenolic glycolipid during ENL in leprosy patients. In t J Lepr. 1985; 53: 211– 217. 58 Truman RN, Shannon EJ, Hasting RS. Host responses to the phenolic glycolipid I antigens of M. leprae (abstract). Twentieth joint Leprosy Research Conference. leprae Int J Lepr. 1985; 53: 710– 711. 59 de Azevedo MP, de Melo PH. Comparative study of complementary activity of serum in polar forms of leprosy and in leprosy reactions. Int J Lepr. 1966; 34: 34– 38. 60 Saitz EW, Dierks RE, Shepard CC. Complement and second component of complement in leprosy. Int J Lepr. 1968; 36: 400– 403. 61 Sheagren JB, Trautman JR, Wolff SM. Immunologic reactivity in leprosy. Clin Res. 1967; 15: 300– 304. 62 Petchclai B, Khupulsup K, Sampathavarich S, et al. C1 q binding, conglutinin binding test, and C3d quantitation (abstract). XIIth International Leprosy Congress. Int J Lepr. 1984; 52(Suppl): 705. 63 Mathews LJ, Trautman JR. Clinical and serologic profiles in leprosy. Lancet. 1965; 2: 915– 918. 64 Malviya AN, Pasricha A, Pasricha JS, et al. Significance of serologic abnormalities in lepromatous leprosy. Int J Lepr. 1972; 40: 361– 365. 65 Scheinberg NA, Masuda A, Benson MP, et al. Serum amyloid protein-SAA, C-reactive protein and lysozymes in leprosy. Int J Lepr. 1979; 47: 133– 137. 66 Ramanathan VD. Reactions in leprosy (abstract). Indo-US Symposium on Immunology and Molecular Biology of Leprosy, New Delhi, India, 1986: 24– 26. 67 Izaki M, Kion S. Fibrinolytic phenomenon in ENL with special reference to its pathogenesis and treatment. Int J Lepr. 1968; 36: 639. 68 Saha K, Agarwal SK, Sehgal VN. Status of fibrin degradation products in Leprosy. J Dermatol (Tokyo). 1984; 11: 545– 549. 69 Saha K, Bhatnagar A, Sharma VK, et al. Enzyme immunoassay of serum beta-2-microglobulin levels in various histologic forms of leprosy with special reference to its elevation in type I and type II lepra reactions. J Clin Microbiol. 1985; 21: 658– 661. 70 Audier AC. Changes in the activity of blood plasmin after administration of 3-pyridyl acetic acid in leprosy. Correlation of activity changes with the Mitsuda reaction. Int J Lepr. 1968; 36: 405– 412. 71 Meyers WM. Importance of plasma fibrinolytic activity in leprosy patients. Int J Lepr. 1969; 37: 343– 350. 72 Waldorf DS, Shagren JN, Trautman JR. Impaired hypersensitivity in patients with lepromatous leprosy. Lancet. 1966; 2: 773– 777. 73 Nath I. Immunology of human leprosy–current status. Lepr Rev. 1983(special issue); 31S– 45S. 74 Lim SD, Jacobson RR, Park BH, et al. Quantitative analysis of thymus-derived lymphocyte responses to phytohaemagglutinin in leprosy. Int J Lepr. 1975; 43: 95– 100. 75 Rea TH, Tohida T. Serum macrophage migration inhibition activity in patients with leprosy. J Invest Dermatol. 1982; 79: 336– 339. 76 Stech JL, Strobal M, Fumovix F, et al. Defect in generation of cytotoxic T-cells in lepromatous leprosy. Clin Exp Immunol. 1982; 46: 633– 640. 77 Rea TH, Levan NE. Variation in DNCB responsivity in untreated leprosy: evidence for a beneficial role for anergy. Int J Lepr. 1980; 48: 120– 125. 78 Lim S, Kiszhiss DF, Jacobson RR. Thymus dependent lymphocytes of peripheral blood in leprosy patients. Infect Immun. 1974; 9: 394– 399. 79 Modlin RL, Bakke AC, Vaccanro SA, et al. Tissue and blood β-lymphocyte sub-populations in erythema nodosum leprosum. Arch Dermatol. 1985; 121: 216– 219. 80 Bach MA, Chatenond L, Wallach D, et al. Studies on T-cell subsets and functions in leprosy. Clin Exp Immunol. 1981; 41: 491– 500. 81 Wallach D, Cottentol F, Bachs MA. Imbalances in T-cell sub- population in lepromatous leprosy. Int J Lepr. 1982; 50: 282– 290. 82 Mashana RN, Harigewoin A, Harboe M, et al. Thymus-dependent lymphocytes in leprosy. I: T lymphocyte subpopulations defined by monoclonal antibodies. Int J Lepr. 1982; 50: 291– 296. 83 Wallach D, Flageul B, Cottentot F, et al. Patients with ENL lack suppressor cells. Arch Dermatol 1985; 121: 1379. 84 Bullock WE, Watson S, Nelson KE, et al. Immunoregulatory control of B-lymphocyte fraction in lepromatous leprosy. Clin Exp Immunol. 1982; 49: 105– 114. 85 Wallach D, Hageril B, Batch MA. Cellular contents of dermal granulomas an immunohistologic approach. Int J Lepr. 1984; 52: 318– 326. 86 Modlin RL, Mehra V, Jordan R, et al. In situ characterization of the cellular immune responses in ENL. J Immunol. 1986; 136: 883– 886. 87 Modlin RL, Hofman FM, Horwitz DA, et al. In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin-2 and its receptors. J Immunol. 1984; 132: 3085– 3090. 88 Heregenilin A, Godal T, Mustafa AS, et al. T-cell-conditioned media reverse T-cell unresponsiveness in lepromatous leprosy. Nature. 1982; 303: 342– 344. 89 Tung KSK, Nelson K, Rubin L, et al. Serum soluble interleukin-2 receptors in leprosy patient. Twentieth Joint Leprosy Research Conference. Int J Lepr. 1985; 53: 719. Citing Literature Volume27, Issue3April 1988Pages 157-162 ReferencesRelatedInformation